Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysis.

Morgan CL, Inzucchi SE, Puelles J, Jenkins-Jones S, Currie CJ.

Diabetes Obes Metab. 2018 May 7. doi: 10.1111/dom.13344. [Epub ahead of print]

PMID:
29732718
2.

Polycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes.

Berni TR, Morgan CL, Berni ER, Rees DA.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2116-2125. doi: 10.1210/jc.2017-02667.

PMID:
29648599
3.

Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia.

Jenkins-Jones S, Parviainen L, Porter J, Withe M, Whitaker MJ, Holden SE, Morgan CL, Currie CJ, Ross RJM.

Eur J Endocrinol. 2018 Apr;178(4):309-320. doi: 10.1530/EJE-17-0895. Epub 2018 Jan 25.

PMID:
29371334
4.

A novel inactivated vaccine against Lawsonia intracellularis induces rapid induction of humoral immunity, reduction of bacterial shedding and provides robust gut barrier function.

Roerink F, Morgan CL, Knetter SM, Passat MH, Archibald AL, Ait-Ali T, Strait EL.

Vaccine. 2018 Mar 7;36(11):1500-1508. doi: 10.1016/j.vaccine.2017.12.049. Epub 2018 Jan 11.

5.

Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study.

Morgan CL, Qiao Q, Grandy S, Johnsson K, Jenkins-Jones S, Holden S, Currie CJ.

Diabetes Ther. 2018 Feb;9(1):269-283. doi: 10.1007/s13300-017-0359-z. Epub 2018 Jan 9.

6.

The risk of cardiac failure following metal-on-metal hip arthroplasty.

Sabah SA, Moon JC, Jenkins-Jones S, Morgan CL, Currie CJ, Wilkinson JM, Porter M, Captur G, Henckel J, Chaturvedi N, Kay P, Skinner JA, Hart AJ, Manisty C.

Bone Joint J. 2018 Jan;100-B(1):20-27. doi: 10.1302/0301-620X.100B1.BJJ-2017-1065.R1.

PMID:
29305446
7.

Impact of differing glucose-lowering regimens on the pattern of association between glucose control and survival.

Currie CJ, Holden SE, Jenkins-Jones S, Morgan CL, Voss B, Rajpathak SN, Alemayehu B, Peters JR, Engel SS.

Diabetes Obes Metab. 2018 Apr;20(4):821-830. doi: 10.1111/dom.13155. Epub 2017 Dec 8.

8.

Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa.

Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V.

Br J Dermatol. 2018 Apr;178(4):917-924. doi: 10.1111/bjd.16101. Epub 2018 Feb 22.

PMID:
29094346
9.

Direct medical costs of severe hypoglycaemic events in patients with type 2 diabetes in England: A retrospective database study.

Holbrook T, Tang Y, Das R, Shankar RR, Tunceli K, Williams J, Radican L, Holden SE, Morgan CL, Piercy J, Currie CJ.

Int J Clin Pract. 2017 Jun;71(6). doi: 10.1111/ijcp.12958. Epub 2017 May 23.

PMID:
28544081
10.

Impact of cognition and noise reduction on speech perception in adults with unilateral cochlear implants.

Purdy SC, Welch D, Giles E, Morgan CL, Tenhagen R, Kuruvilla-Mathew A.

Cochlear Implants Int. 2017 May;18(3):162-170. doi: 10.1080/14670100.2017.1299393. Epub 2017 Mar 24.

PMID:
28335695
11.

Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study.

Holden SE, Morgan CL, Qiao Q, Jenkins-Jones S, Berni ER, Currie CJ.

Diabetes Obes Metab. 2017 Aug;19(8):1097-1105. doi: 10.1111/dom.12916. Epub 2017 Mar 31.

PMID:
28218819
12.

Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013.

Holden SE, Jenkins-Jones S, Morgan CL, Peters JR, Schernthaner G, Currie CJ.

Diabet Med. 2017 Jun;34(6):770-780. doi: 10.1111/dme.13332. Epub 2017 Mar 9.

PMID:
28173634
13.

Syllabus Selection: Innovative Learning Activity.

Minchew LA, Morgan CL.

J Nurs Educ. 2016 Nov 1;55(11):663-664. doi: 10.3928/01484834-20161011-11. No abstract available.

PMID:
27783823
14.

Unmanned Aerial Vehicles for High-Throughput Phenotyping and Agronomic Research.

Shi Y, Thomasson JA, Murray SC, Pugh NA, Rooney WL, Shafian S, Rajan N, Rouze G, Morgan CL, Neely HL, Rana A, Bagavathiannan MV, Henrickson J, Bowden E, Valasek J, Olsenholler J, Bishop MP, Sheridan R, Putman EB, Popescu S, Burks T, Cope D, Ibrahim A, McCutchen BF, Baltensperger DD, Avant RV Jr, Vidrine M, Yang C.

PLoS One. 2016 Jul 29;11(7):e0159781. doi: 10.1371/journal.pone.0159781. eCollection 2016.

15.

Non-Response to Antibiotic Treatment in Adolescents for Four Common Infections in UK Primary Care 1991-2012: A Retrospective, Longitudinal Study.

Berni E, Scott LA, Jenkins-Jones S, De Voogd H, Rocha MS, Butler CC, Morgan CL, Currie CJ.

Antibiotics (Basel). 2016 Jul 4;5(3). pii: E25. doi: 10.3390/antibiotics5030025.

16.

Natural History of Patients Taking Rifaximin-╬▒ for Recurrent Hepatic Encephalopathy and Risk of Future Overt Episodes and Mortality: A Post-hoc Analysis of Clinical Trials Data.

Bannister CA, Orr JG, Reynolds AV, Hudson M, Conway P, Radwan A, Morgan CL, Currie CJ.

Clin Ther. 2016 May;38(5):1081-1089.e4. doi: 10.1016/j.clinthera.2016.03.033. Epub 2016 Apr 30.

PMID:
27136714
17.

Comparative estimated effectiveness of antibiotic classes as initial and secondary treatments of respiratory tract infections: longitudinal analysis of routine data from UK primary care 1991-2012.

Berni E, Butler CC, Jenkins-Jones S, de Voogd H, Ouwens M, Morgan CL, Currie CJ.

Curr Med Res Opin. 2016 Jun;32(6):1023-32. doi: 10.1185/03007995.2016.1157459. Epub 2016 Mar 11.

PMID:
26907677
18.

Contemporary Reproductive Outcomes for Patients With Polycystic Ovary Syndrome: A Retrospective Observational Study.

Rees DA, Jenkins-Jones S, Morgan CL.

J Clin Endocrinol Metab. 2016 Apr;101(4):1664-72. doi: 10.1210/jc.2015-2682. Epub 2016 Feb 9.

19.

The Burden of Illness of Congenital Adrenal Hyperplasia In The United Kingdom: A Retrospective, Observational Study.

Jenkins-Jones S, Whitaker MJ, Holden SE, Morgan CL, Ross RJ, Currie CJ.

Value Health. 2015 Nov;18(7):A749. doi: 10.1016/j.jval.2015.09.2896. Epub 2015 Oct 20. No abstract available.

20.

Association of Adverse Events And Health Service Usage With Tapentadol Prolonged-Release Treatment Compared With Morphine Controlled-Release (Cr) And Oxycodone Cr: A Uk Primary Care Observational Study.

Baxter G, Morgan CL, Jenkins-Jones S, Currie CJ, Schultewolter D.

Value Health. 2015 Nov;18(7):A658. doi: 10.1016/j.jval.2015.09.2385. Epub 2015 Oct 20. No abstract available.

21.

Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.

Holden SE, Jenkins-Jones S, Morgan CL, Schernthaner G, Currie CJ.

Diabetes Obes Metab. 2015 Apr;17(4):350-62. doi: 10.1111/dom.12412. Epub 2014 Dec 10.

PMID:
25399739
22.

Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis.

Currie CJ, Berni E, Jenkins-Jones S, Poole CD, Ouwens M, Driessen S, de Voogd H, Butler CC, Morgan CL.

BMJ. 2014 Sep 23;349:g5493. doi: 10.1136/bmj.g5493.

23.

Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugs.

Emery P, Gallo G, Boyd H, Morgan CL, Currie CJ, Poole CD, Nab HW.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):653-60. Epub 2014 Sep 5.

PMID:
25190189
24.

Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls.

Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP, Schernthaner G, Mukherjee J, Currie CJ.

Diabetes Obes Metab. 2014 Nov;16(11):1165-73. doi: 10.1111/dom.12354. Epub 2014 Jul 31.

PMID:
25041462
25.

Use of 5% lidocaine medicated plasters for the treatment of pain in routine hospital practice: patient reported pain, functioning and satisfaction.

Khot S, Morgan CL, Kadambande S, Poole CD.

Curr Med Res Opin. 2014 Aug;30(8):1573-8. doi: 10.1185/03007995.2014.915212. Epub 2014 May 12.

PMID:
24773481
26.

Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality.

Morgan CL, Mukherjee J, Jenkins-Jones S, Holden SE, Currie CJ.

Diabetes Obes Metab. 2014 Oct;16(10):977-83. doi: 10.1111/dom.12306. Epub 2014 May 22.

PMID:
24762119
27.

Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study.

Morgan CL, Mukherjee J, Jenkins-Jones S, Holden SE, Currie CJ.

Diabetes Obes Metab. 2014 Oct;16(10):957-62. doi: 10.1111/dom.12302. Epub 2014 May 8.

PMID:
24720708
28.

The effect of withdrawal of rosiglitazone on treatment pathways, diabetes control and patient outcomes: a retrospective cohort study.

Morgan CL, Puelles J, Poole CD, Currie CJ.

J Diabetes Complications. 2014 May-Jun;28(3):360-4. doi: 10.1016/j.jdiacomp.2014.01.007. Epub 2014 Jan 17.

PMID:
24529918
29.

Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study.

Morgan CL, Owens DR, Aubonnet P, Carr ES, Jenkins-Jones S, Poole CD, Currie CJ.

BMJ Open. 2013 Dec 3;3(12):e004025. doi: 10.1136/bmjopen-2013-004025.

30.

Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data.

Morgan CL, Emery P, Porter D, Reynolds A, Young A, Boyd H, Poole CD, Currie CJ.

Rheumatology (Oxford). 2014 Jan;53(1):186-94. doi: 10.1093/rheumatology/ket333. Epub 2013 Oct 18.

PMID:
24140761
31.

The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010).

Holden SE, Jenkins-Jones S, Poole CD, Morgan CL, Coghill D, Currie CJ.

Child Adolesc Psychiatry Ment Health. 2013 Oct 11;7(1):34. doi: 10.1186/1753-2000-7-34.

32.

External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations.

Bannister CA, Poole CD, Jenkins-Jones S, Morgan CL, Elwyn G, Spasic I, Currie CJ.

Diabetes Care. 2014 Feb;37(2):537-45. doi: 10.2337/dc13-1159. Epub 2013 Oct 2.

PMID:
24089541
33.

The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010.

Holden SH, Barnett AH, Peters JR, Jenkins-Jones S, Poole CD, Morgan CL, Currie CJ.

Diabetes Obes Metab. 2013 Sep;15(9):844-52. doi: 10.1111/dom.12123. Epub 2013 May 16.

PMID:
23675742
34.

Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes.

Currie CJ, Poole CD, Evans M, Peters JR, Morgan CL.

J Clin Endocrinol Metab. 2013 Feb;98(2):668-77. doi: 10.1210/jc.2012-3042. Epub 2013 Jan 31.

35.

The impact of treatment non-compliance on mortality in people with type 1 diabetes.

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M.

J Diabetes Complications. 2013 May-Jun;27(3):219-23. doi: 10.1016/j.jdiacomp.2012.10.006. Epub 2012 Nov 13.

PMID:
23157988
36.

Stimulus level effects on speech-evoked obligatory cortical auditory evoked potentials in infants with normal hearing.

Purdy SC, Sharma M, Munro KJ, Morgan CL.

Clin Neurophysiol. 2013 Mar;124(3):474-80. doi: 10.1016/j.clinph.2012.09.011. Epub 2012 Oct 30.

PMID:
23117114
37.

What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes.

Morgan CL, Poole CD, Evans M, Barnett AH, Jenkins-Jones S, Currie CJ.

J Clin Endocrinol Metab. 2012 Dec;97(12):4605-12. doi: 10.1210/jc.2012-3034. Epub 2012 Oct 17.

PMID:
23076348
38.

Assessing spatial variability of soil petroleum contamination using visible near-infrared diffuse reflectance spectroscopy.

Chakraborty S, Weindorf DC, Zhu Y, Li B, Morgan CL, Ge Y, Galbraith J.

J Environ Monit. 2012 Nov;14(11):2886-92. doi: 10.1039/c2em30330b.

PMID:
22986574
39.

Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.

Morgan CL, Jenkins-Jones S, Currie CJ, Rees DA.

J Clin Endocrinol Metab. 2012 Sep;97(9):3251-60. doi: 10.1210/jc.2012-1690. Epub 2012 Jul 5.

PMID:
22767635
40.

The impact of treatment noncompliance on mortality in people with type 2 diabetes.

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M.

Diabetes Care. 2012 Jun;35(6):1279-84. doi: 10.2337/dc11-1277. Epub 2012 Apr 17.

41.

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival.

Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL.

Diabetes Care. 2012 Feb;35(2):299-304. doi: 10.2337/dc11-1313. Epub 2012 Jan 20.

42.

Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs.

Morgan CL, Jenkins-Jones S, Evans M, Barnett AH, Poole CD, Currie CJ.

Diabetes Obes Metab. 2012 May;14(5):424-32. doi: 10.1111/j.1463-1326.2011.01552.x. Epub 2012 Jan 17.

PMID:
22192841
43.

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin.

Holden SE, Poole CD, Morgan CL, Currie CJ.

BMJ Open. 2011 Jan 1;1(2):e000258. doi: 10.1136/bmjopen-2011-000258.

44.

Effect of diet composition on the determination of ash and moisture content in solid cattle manure using visible and near-infrared spectroscopy.

Sakirkin SL, Morgan CL, MacDonald JC, Auvermann BW.

Appl Spectrosc. 2011 Sep;65(9):1056-61. doi: 10.1366/11-06333.

PMID:
21929861
45.

Satisfaction, demand, and opening hours in primary care: an observational study.

Morgan CL, Beerstecher HJ.

Br J Gen Pract. 2011 Aug;61(589):e498-507. doi: 10.3399/bjgp11X588475.

46.

The relationship between self-reported severe pain and measures of socio-economic disadvantage.

Morgan CL, Conway P, Currie CJ.

Eur J Pain. 2011 Nov;15(10):1107-11. doi: 10.1016/j.ejpain.2011.04.010. Epub 2011 May 26.

PMID:
21620747
47.

Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study.

Morgan CL, Evans M, Toft AD, Jenkins-Jones S, Poole CD, Currie CJ.

Clin Ther. 2011 Jan;33(1):27-35. doi: 10.1016/j.clinthera.2011.01.023. Erratum in: Clin Ther. 2011 Mar;33(3):391.

PMID:
21397771
48.

Rapid identification of oil-contaminated soils using visible near-infrared diffuse reflectance spectroscopy.

Chakraborty S, Weindorf DC, Morgan CL, Ge Y, Galbraith JM, Li B, Kahlon CS.

J Environ Qual. 2010 Jul-Aug;39(4):1378-87.

PMID:
20830926
49.

Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region.

Morgan CL, Peters JR, Dixon S, Currie CJ.

Diabet Med. 2010 Sep;27(9):1066-73. doi: 10.1111/j.1464-5491.2010.03086.x.

PMID:
20722682
50.

A longitudinal study into the new and long-term use of self-monitoring blood glucose strips in the UK.

Morgan CL, Griffin A, Chamberlain GH, Turkiendorf A, McEwan P, Evans LM, Owens DR.

Diabetes Ther. 2010 Aug;1(1):1-9. doi: 10.1007/s13300-010-0001-9. Epub 2010 Jul 28.

Supplemental Content

Loading ...
Support Center